UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 6, 2006
TUTOGEN MEDICAL, INC.
(Registrant’s telephone number, including area code)
| |
|
|
|
|
| Florida
|
|
0-16128
|
|
59-3100165 |
| |
| (State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer |
| of incorporation)
|
|
File Number)
|
|
Identification No.) |
13709 Progress Boulevard, Box 19
Alachua, Florida 32615
(Address of principal executive offices)
(386) 462-0402
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 8.01 Other Events
On November 6, 2006, at a duly called meeting of the Board of Directors, the Board adopted Amended and Restated By-laws, a copy of which is attached hereto as Exhibit 3(ii)
Item 9.01 Financial Statements and Exhibits
| |
|
|
|
|
| Exhibits |
|
|
| |
|
|
|
|
| |
3(ii) |
|
|
Amended and Restated By-laws. |
2